Observational studyRheumatology international2025
Impact of gastrointestinal involvement on mortality and malnutrition in systemic sclerosis: an observational cohort of 135 patients.
Observational study in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systemic sclerosis and small bowel involvement: A systematic review of diagnostic approaches and current evidence.Seminars in arthritis and rheumatism · 2026Pooled it
- Sex-specific associations between nutritional status, disease activity, and fatigue in psoriatic arthritis: a cross-sectional analysis.Rheumatology international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To describe the characteristics and outcomes of gastrointestinal involvement (GI) in patients with systemic sclerosis (SSc). We also assessed the impact of GI on mortality, hospitalizations, and undernutrition and identified the subgroup affected by chronic intestinal pseudo-obstruction (CIPO). We conducted an observational monocentric study including 135 consecutive patients with SSc and evaluated clinical and paraclinical data, laboratory data and nutritional data at disease onset and at the last follow-up over a median follow-up of 89 months. We assessed hospitalizations and their main causes at 6 years. A total of 135 patients with SSc (95 women, median age 57 years) were included. GI affected 116 patients (86%) over the entire follow-up period, with gastroesophageal reflux as the main complaint (70%). The anti-Pm/Scl antibody seems to be predictive of secondary GI, with a greater prevalence in this group (p = 0.007). Undernutrition was present exclusively in patients with GI (p = 0,01) and affected 22% of patients at the last follow-up, with a higher mortality risk (38% vs. 11%, Fischer p = 0.001; CI 95% [1.88–13.28]). It affected older patients (p = 0.004), with greater muscular involvement (p = 0.02) and higher levels of acute phase reactants (p = 0.01). CIPO affected 8% of our cohort (n = 8) and appears mostly within the first 6 years after the onset of SSc. Digestive tract involvement affects almost all patients and should be recognized as an integral aspect of SSc care. Undernutrition is a severe complication and should be detected as part of GI.
Indexed as
Identifiers
41128889What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.